166 related articles for article (PubMed ID: 34217824)
1. Colon-targeted delivery of tacrolimus using pH-responsive polymeric nanoparticles for murine colitis therapy.
Cai X; Wang X; He M; Wang Y; Lan M; Zhao Y; Gao F
Int J Pharm; 2021 Sep; 606():120836. PubMed ID: 34217824
[TBL] [Abstract][Full Text] [Related]
2. Colon-Targeted Therapy of Tacrolimus (FK506) in the Treatment of Experimentally Induced Colitis.
Ali AS; Altayari AA; Khan LM; Alharthi SE; Ahmed OA; El-Shitany NA; Ali SS; Saadah OI
Pharmacology; 2020; 105(9-10):541-549. PubMed ID: 31940656
[TBL] [Abstract][Full Text] [Related]
3. XA pH-Responsive and Colitis-Targeted Nanoparticle Loaded with Shikonin for the Oral Treatment of Inflammatory Bowel Disease in Mice.
Feng J; Wang Y; Lv Y; Fang S; Ren M; Yao M; Lan M; Zhao Y; Gao F
Mol Pharm; 2022 Nov; 19(11):4157-4170. PubMed ID: 36106774
[TBL] [Abstract][Full Text] [Related]
4. pH-sensitive nanoparticles for colonic delivery of curcumin in inflammatory bowel disease.
Beloqui A; Coco R; Memvanga PB; Ucakar B; des Rieux A; Préat V
Int J Pharm; 2014 Oct; 473(1-2):203-12. PubMed ID: 25014369
[TBL] [Abstract][Full Text] [Related]
5. Colon-specific delivery of methotrexate using hyaluronic acid modified pH-responsive nanocarrier for the therapy of colitis in mice.
Lv Y; Ren M; Yao M; Zou J; Fang S; Wang Y; Lan M; Zhao Y; Gao F
Int J Pharm; 2023 Mar; 635():122741. PubMed ID: 36804523
[TBL] [Abstract][Full Text] [Related]
6. Colon-targeted delivery of budesonide using dual pH- and time-dependent polymeric nanoparticles for colitis therapy.
Naeem M; Choi M; Cao J; Lee Y; Ikram M; Yoon S; Lee J; Moon HR; Kim MS; Jung Y; Yoo JW
Drug Des Devel Ther; 2015; 9():3789-99. PubMed ID: 26229440
[TBL] [Abstract][Full Text] [Related]
7. Enhanced therapeutic efficacy of a novel colon-specific nanosystem loading emodin on DSS-induced experimental colitis.
Wang D; Sun M; Zhang Y; Chen Z; Zang S; Li G; Li G; Clark AR; Huang J; Si L
Phytomedicine; 2020 Nov; 78():153293. PubMed ID: 32777486
[TBL] [Abstract][Full Text] [Related]
8. Targeted delivery of budesonide in acetic acid induced colitis: impact on miR-21 and E-cadherin expression.
Seoudi SS; Allam EA; El-Kamel AH; Elkafrawy H; El-Moslemany RM
Drug Deliv Transl Res; 2023 Nov; 13(11):2930-2947. PubMed ID: 37184747
[TBL] [Abstract][Full Text] [Related]
9. Inflammation-triggered local drug release ameliorates colitis by inhibiting dendritic cell migration and Th1/Th17 differentiation.
Regmi S; Pathak S; Nepal MR; Shrestha P; Park J; Kim JO; Yong CS; Choi DY; Chang JH; Jeong TC; Orive G; Yook S; Jeong JH
J Control Release; 2019 Dec; 316():138-149. PubMed ID: 31689461
[TBL] [Abstract][Full Text] [Related]
10. Drug-loaded nanoparticles targeted to the colon with polysaccharide hydrogel reduce colitis in a mouse model.
Laroui H; Dalmasso G; Nguyen HT; Yan Y; Sitaraman SV; Merlin D
Gastroenterology; 2010 Mar; 138(3):843-53.e1-2. PubMed ID: 19909746
[TBL] [Abstract][Full Text] [Related]
11. Endogenous stem cell mobilization and localized immunosuppression synergistically ameliorate DSS-induced Colitis in mice.
Regmi S; Pathak S; Chaudhary D; Kim JO; Nam JW; Kim HS; Jiang HL; Ryu D; Sung JH; Yook S; Jeong JH
Stem Cell Res Ther; 2024 Jun; 15(1):167. PubMed ID: 38872206
[TBL] [Abstract][Full Text] [Related]
12. pH-Sensitive Nanoparticles for Colonic Delivery Anti-miR-301a in Mouse Models of Inflammatory Bowel Diseases.
Wang J; Yao M; Zou J; Ding W; Sun M; Zhuge Y; Gao F
Nanomaterials (Basel); 2023 Oct; 13(20):. PubMed ID: 37887947
[TBL] [Abstract][Full Text] [Related]
13. A ROS-responsive fluorescent probe detecting experimental colitis by functional polymeric nanoparticles.
Wang Y; Wang X; Lv Y; Guo Y; He M; Lan M; Zhao Y; Gao F
Int J Pharm; 2021 Nov; 609():121125. PubMed ID: 34560209
[TBL] [Abstract][Full Text] [Related]
14. Multifunctional Poly(methyl vinyl ether-co-maleic anhydride)-graft-hydroxypropyl-β-cyclodextrin Amphiphilic Copolymer as an Oral High-Performance Delivery Carrier of Tacrolimus.
Zhang D; Pan X; Wang S; Zhai Y; Guan J; Fu Q; Hao X; Qi W; Wang Y; Lian H; Liu X; Wang Y; Sun Y; He Z; Sun J
Mol Pharm; 2015 Jul; 12(7):2337-51. PubMed ID: 26024817
[TBL] [Abstract][Full Text] [Related]
15. Drug delivery to inflamed colon by nanoparticles: comparison of different strategies.
Coco R; Plapied L; Pourcelle V; Jérôme C; Brayden DJ; Schneider YJ; Préat V
Int J Pharm; 2013 Jan; 440(1):3-12. PubMed ID: 22820482
[TBL] [Abstract][Full Text] [Related]
16. Tacrolimus nanoparticles based on chitosan combined with nicotinamide: enhancing percutaneous delivery and treatment efficacy for atopic dermatitis and reducing dose.
Yu K; Wang Y; Wan T; Zhai Y; Cao S; Ruan W; Wu C; Xu Y
Int J Nanomedicine; 2018; 13():129-142. PubMed ID: 29317821
[TBL] [Abstract][Full Text] [Related]
17. Hyaluronic acid modified oral drug delivery system with mucoadhesiveness and macrophage-targeting for colitis treatment.
Zhang Y; Ma R; You C; Leng X; Wang D; Deng S; He B; Guo Z; Guan Z; Lei H; Yu J; Zhou Q; Xing J; Dong Y
Carbohydr Polym; 2023 Aug; 313():120884. PubMed ID: 37182972
[TBL] [Abstract][Full Text] [Related]
18. Colon-targeted piperine-glycyrrhizic acid nanocrystals for ulcerative colitis synergetic therapy
Wu X; Zhang Q; Peng L; Tian Z; Gou G; Zuo W; Yang J
J Mater Chem B; 2024 Feb; 12(6):1604-1616. PubMed ID: 38269414
[TBL] [Abstract][Full Text] [Related]
19. Nanoparticles in inflammatory bowel disease: particle targeting versus pH-sensitive delivery.
Meissner Y; Pellequer Y; Lamprecht A
Int J Pharm; 2006 Jun; 316(1-2):138-43. PubMed ID: 16675176
[TBL] [Abstract][Full Text] [Related]
20. Combination of hydrotropic nicotinamide with nanoparticles for enhancing tacrolimus percutaneous delivery.
Pan W; Qin M; Zhang G; Long Y; Ruan W; Pan J; Wu Z; Wan T; Wu C; Xu Y
Int J Nanomedicine; 2016; 11():4037-50. PubMed ID: 27578973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
